Acionna Therapeutics Ltd
Research and experimental development on biotechnology · Huntingdon
ActiveUnited KingdomIncorporated 2025Private Limited Company
Financial position
Accounts to 2026-03-31 · GBP · Company accounts
Net assets
£4,476,162
Cash
£4,227,537
Turnover
—
Profit / loss
—
Current assets
£4,819,960
Creditors < 1 year
£446,413
Equity
£4,476,162
Average employees
3
Balance-sheet trend
GBP · companyTwo periods with a known, matching scope are needed for a trend.
Financial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2026-03-31Company |
|---|---|
| Balance sheet | |
| Net assets | £4,476,162 |
| Equity | £4,476,162 |
| Assets | |
| Fixed assets | £102,615 |
| Property, plant & equipment | £6,157 |
| Current assets | £4,819,960 |
| Cash at bank | £4,227,537 |
| Debtors | £592,423 |
| Liabilities | |
| Creditors within one year | £446,413 |
| Net current assets | £4,373,547 |
| Assets less current liabilities | £4,476,162 |
| People | |
| Average employees | 3 |
| Source evidence | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesNo charges available in our records.